Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Palliat Med ; 2024 Feb 13.
Article in English | MEDLINE | ID: mdl-38350116

ABSTRACT

Background: Patients with life-limiting illnesses receiving palliative care have a high symptom burden that can be challenging to manage. Guided imagery (GI), a complementary and integrative therapy in which patients are induced to picture mental images with sensory components, has proven in quasi-experimental studies to be effective as a complementary therapy for symptom management. Objective: To systematically review randomized controlled trials that report evidence of guided imagery for symptom management in patients with life-limiting illnesses. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline was followed for this review and the search strategy was applied in Medline, CINHAL, and Web of Science. The quality of articles was evaluated using the Cochrane Collaboration's Risk-of-Bias Tool 2 (RoB 2). The results are presented using the Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. Results: A total of 8822 studies were initially identified through the search strategy, but after applying exclusion criteria, 14 randomized controlled trials were included in this review. The quality assessment revealed that four studies had a high risk of bias, nine had some concerns, and one had a low risk of bias. Out of the 14 studies, 6 evaluated oncological diagnosis, while the remaining 8 focused on nononcological diagnoses across 6 different diseases. GI was found to be effective in managing symptoms in 10 out of the 14 studies. Regardless of the disease stage, patients who received guided imagery experienced relief from anxiety, depression, pain, sleep disturbances, and fatigue. Conclusion: GI therapy has shown promising results regarding symptom management in palliative care patients with life-limiting illnesses at different stages.

2.
SAGE Open Med Case Rep ; 11: 2050313X231157483, 2023.
Article in English | MEDLINE | ID: mdl-36890802

ABSTRACT

Difficult visceral cancer pain is defined as pain that does not improve with conventional non-pharmacological and pharmacological strategies, including opioids and adjuvants, and occurs in up to 15% of patients with cancer. In oncological practice, we must be prepared to establish strategies for dealing with such complex cases. Different analgesic strategies have been described in the literature, including managing refractory pain through palliative sedation; however, this might become a dilemma from a clinical and bioethical point of view in end-of-life situations. We present the case of a young male patient with moderately differentiated intestinal-type adenocarcinoma of the left colon, with intra-abdominal sepsis, and for whom despite the multimodal treatment for difficult visceral cancer pain, the pain was refractory leading to palliative sedation. Difficult visceral cancer pain is a pathology that affects the quality of life of patients and is a challenge for pain specialists, for both pharmacological and non-pharmacological management.

3.
Cad Saude Publica ; 34(10): e00193617, 2018 10 11.
Article in English | MEDLINE | ID: mdl-30329003

ABSTRACT

Bacteria belonging to Anaplasma, Ehrlichia, Rickettsia and Coxiella genera are considered emerging pathogens and livestock is one of the contexts where the transmission of these microorganisms can occur. The goal of this study was to determine serological evidence for the exposure to these bacteria in cattle and humans with occupational exposure to livestock in the subregions North and Magdalena Medio, Antioquia, Colombia, and to explore related factors. A cross-sectional study was conducted in 48 livestock farms distributed in six municipalities from both subregions: Belmira, Entrerríos and San Pedro de los Milagros (North), and Puerto Berrío, Puerto Nare and Puerto Triunfo (Magdalena Medio). Blood samples from 332 people and 384 bovines were evaluated by serology (IgM and IgG) screening for bacteria from the Anaplasma, Ehrlichia, Rickettsia, and Coxiella genera. Seropositivity in humans from both regions was 42.4% (95%CI: 31.2-55.1) for Anaplasma, 74.2% (95%CI: 66.0-84.4) for Ehrlichia, 72.5% (95%CI: 62.1-82.0) for Rickettsia, and 60.7% (95%CI: 59.7-69.1) for Coxiella burnetii. In cattle, seropositivity was 31.6% (95%CI: 19.9-44.2), 66.8% (95%CI: 55.2-78.1), 64.6% (95%CI: 53.8-74.5), and 61.6% (95%CI: 51.9-69.2), respectively. History of biting by ticks, milking, vaccination, having dogs and hens in the residence, as well as the consumption of raw milk derivatives were some factors associated with the infection by the bacteria studied. The results suggest a previous and recent exposure to these zoonotic bacteria genera in people with occupational exposure to livestock, as well as in cattle in the two studied subregions.


Subject(s)
Gram-Negative Bacterial Infections/transmission , Occupational Exposure/statistics & numerical data , Zoonoses/transmission , Adult , Aged , Aged, 80 and over , Anaplasma/isolation & purification , Animals , Cattle , Colombia , Coxiella burnetii/isolation & purification , Cross-Sectional Studies , Ehrlichia/isolation & purification , Female , Gram-Negative Bacterial Infections/blood , Gram-Negative Bacterial Infections/microbiology , Humans , Male , Middle Aged , Rickettsia/isolation & purification , Zoonoses/blood , Zoonoses/microbiology
4.
Cad. Saúde Pública (Online) ; 34(10): e00193617, oct. 2018. tab, graf
Article in English | LILACS | ID: biblio-952356

ABSTRACT

Bacteria belonging to Anaplasma, Ehrlichia, Rickettsia and Coxiella genera are considered emerging pathogens and livestock is one of the contexts where the transmission of these microorganisms can occur. The goal of this study was to determine serological evidence for the exposure to these bacteria in cattle and humans with occupational exposure to livestock in the subregions North and Magdalena Medio, Antioquia, Colombia, and to explore related factors. A cross-sectional study was conducted in 48 livestock farms distributed in six municipalities from both subregions: Belmira, Entrerríos and San Pedro de los Milagros (North), and Puerto Berrío, Puerto Nare and Puerto Triunfo (Magdalena Medio). Blood samples from 332 people and 384 bovines were evaluated by serology (IgM and IgG) screening for bacteria from the Anaplasma, Ehrlichia, Rickettsia, and Coxiella genera. Seropositivity in humans from both regions was 42.4% (95%CI: 31.2-55.1) for Anaplasma, 74.2% (95%CI: 66.0-84.4) for Ehrlichia, 72.5% (95%CI: 62.1-82.0) for Rickettsia, and 60.7% (95%CI: 59.7-69.1) for Coxiella burnetii. In cattle, seropositivity was 31.6% (95%CI: 19.9-44.2), 66.8% (95%CI: 55.2-78.1), 64.6% (95%CI: 53.8-74.5), and 61.6% (95%CI: 51.9-69.2), respectively. History of biting by ticks, milking, vaccination, having dogs and hens in the residence, as well as the consumption of raw milk derivatives were some factors associated with the infection by the bacteria studied. The results suggest a previous and recent exposure to these zoonotic bacteria genera in people with occupational exposure to livestock, as well as in cattle in the two studied subregions.


Las bacterias pertenecientes a los géneros Anaplasma, Ehrlichia, Rickettsia y Coxiella son consideradas patógenos emergentes y la ganadería es uno de los contextos donde se puede producir la transmisión de este tipo de microorganismos. El objetivo de este estudio fue determinar la evidencia serológica, debida a la exposición a estas bacterias en bovinos y humanos con exposición ocupacional a ganadería en las subregiones Norte y Magdalena Medio, Antioquia, Colombia, además de estudiar los factores relacionados. Se realizó un estudio transversal en 48 fincas ganaderas, distribuidas en seis municipios de ambas subregiones: Belmira, Entrerríos y San Pedro de los Milagros (Norte), y Puerto Berrío, Puerto Nare y Puerto Triunfo (Magdalena Medio). Las muestras de sangre de 332 personas y 384 bovinos fueron evaluadas mediante tamización serológica (IgM e IgG) para la detección de bacterias de los géneros Anaplasma, Ehrlichia, Rickettsia, y Coxiella. La seropositividad en humanos de ambas regiones fue 42,4% (IC95%: 31,2-55,1) en el caso de Anaplasma, un 74,2% (IC95%: 66,0-84,4) en Ehrlichia, un 72,5% (IC95%: 62,1-82,0) en Rickettsia, y un 60,7% (IC95%: 59,7-69,1) en Coxiella burnetii. En los bovinos, la seropositividad fue 31,6% (IC95%: 19,9-44,2), 66,8% (IC95%: 55,2-78,1), 64,6% (IC95%: 53,8-74,5), y 61,6% (IC95%: 51,9-69,2), respectivamente. El antecedente de haber sido mordido por garrapatas, ordeñar, vacunación, tener perros y gallinas en la residencia, así como el consumo de derivados de leche cruda fueron algunos de los factores asociados con la infección por las bacterias estudiadas. Los resultados sugieren la exposición previa y reciente a estas bacterias en personas con una exposición ocupacional a la ganadería, así como a los bovinos en las dos subregiones estudiadas.


As bactérias dos gêneros Anaplasma, Ehrlichia, Rickettsia e Coxiella são considerados patógenos emergentes, e a transmissão desses microrganismos pode ocorrer no contexto da pecuária. O estudo teve como objetivos determinar as evidências sorológicas de exposição a essas bactérias em bovinos e em humanos com exposição ocupacional ao gado nas sub-regiões Norte e Magdalena Médio, Antióquia, Colômbia, e explorar fatores associados. Foi realizado um estudo transversal em 48 fazendas de gado bovino distribuídas em seis municípios nas duas sub-regiões: Belmira, Entrerríos e San Pedro de los Milagros (Norte) e Puerto Berrío, Puerto Nare e Puerto Triunfo (Magdalena Médio). Amostras de sangue de 332 humanos e 384 bovinos foram analisadas com sorologia (IgM e IgG) para bactérias dos gêneros Anaplasma, Ehrlichia, Rickettsia e Coxiella. Os níveis de sorologia positiva em humanos das duas regiões foram de 42,4% (IC95%: 31,2-55,1) para Anaplasma, 74,2% (IC95%: 66,0-84,4) para Ehrlichia, 72,5% (IC95%: 62,1-82,0) para Rickettsia e 60,7% (IC95%: 59,7-69,1) para Coxiella burnetii. Nos bovinos, os níveis foram 31,6% (IC95%: 19,9-44,2), 66,8% (IC95%: 55,2-78,1), 64,6% (IC95%: 53,8-74,5) e 61,6% (IC95%: 51,9-69,2), respectivamente. Os fatores associados às bactérias estudadas foram: história de picada de carrapato, ordenha, vacinação, presença de cães e galinhas no domicílio e consumo de laticínios feitos com leite cru, entre outros. Os resultados sugerem exposição prévia e recente a esses gêneros bacterianos zoonóticos em pessoas com contato ocupacional com gado, assim como nos próprios animais, nas duas sub-regiões estudadas.


Subject(s)
Humans , Animals , Male , Female , Adult , Aged , Aged, 80 and over , Cattle , Zoonoses/transmission , Occupational Exposure/statistics & numerical data , Gram-Negative Bacterial Infections/transmission , Rickettsia/isolation & purification , Zoonoses/microbiology , Zoonoses/blood , Cross-Sectional Studies , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/blood , Coxiella burnetii/isolation & purification , Colombia , Ehrlichia/isolation & purification , Anaplasma/isolation & purification , Middle Aged
5.
J Dairy Sci ; 100(11): 9294-9297, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28918144

ABSTRACT

Group B Streptococcus or Streptococcus agalactiae continue to be challenging for milk quality programs in countries with emerging dairy industries, such as Colombia, where high prevalence has been reported. Molecular typing of isolates is needed to understand the variability and epidemiology of this pathogen and to develop effective control and eradication programs. We characterized the molecular profile of Strep. agalactiae isolated from cows with subclinical mastitis in 21 Colombian dairy herds and measured diversity within and between herds using multilocus sequence typing. Isolates belonged to sequence type 248 [clonal complex (CC) 103; n = 30), ST1 (CC1; n = 6) or ST22 (CC22; n = 4)], whereas members of CC67/61, the dominant type in North America, were not detected. Presence of multiple clonally unrelated sequence type within a herd was common, which contrasts with the situation in European countries and suggests introduction from multiple sources. Our results demonstrate that conclusions from molecular epidemiological studies in 1 region cannot necessarily be extrapolated to other regions, and no single bovine-adapted CC of Strep. agalactiae exists in Colombia. Improvements in internal and external biosecurity will be needed to reduce Strep. agalactiae prevalence in Colombian dairy herds.


Subject(s)
Mastitis, Bovine/microbiology , Molecular Epidemiology , Streptococcal Infections/veterinary , Streptococcus agalactiae/genetics , Animals , Cattle , Dairying/methods , Female , Global Health , Mastitis, Bovine/epidemiology , Milk/microbiology , Multilocus Sequence Typing , Prevalence , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Streptococcus agalactiae/isolation & purification
6.
Biosalud ; 11(2): 40-51, jul.-dic. 2012. ilus, tab
Article in Spanish | LILACS | ID: lil-682362

ABSTRACT

Entre los agentes contagiosos que inducen mastitis severas en la vaca, se encuentra el Staphylococcus aureus (S. aureus), de difícil cura bacteriológica y alta resistencia antimicrobiana. Debido a que el cultivo microbiológico de las muestras clínicas, solo ofrece resultado en un 50% de los casos (1) el diagnóstico por PCR es una alternativa. El objetivo de este estudio fue probar si los cebadores descritos por Cremonesi et al. (2) para el diagnóstico de S. aureus, como de buena sensibilidad y especificidad, sirven para ser usados en muestras clínicas. Los resultados demostraron que las siguientes secuencias de nucleótidos como cebadores: F 5' AGC TGT GGA TTG TCC TTT GG 3' y R 5' TCG CTC GCT CAC CTT AGA A 3', para obtener un amplificado de 499 pb no sirven en muestras clínicas por su baja especificidad (62,95%). Se requiere buscar nuevos cebadores que amplifiquen regiones del S. aureus que no se compartan con otras bacterias, en especial aquellas que producen mastitis en vacas productoras de leche.


Staphylococcus aureus (S. aureus) is one of the infectious agents that induce severe mastitis in cows with a difficult bacteriological cure and high antimicrobial resistance. Because the microbiological culture of clinical samples only shows results in 50% of the cases (Koskinen et al., 2009), diagnostic through PCR is an alternative. The aim of this study was to prove if the primers described by Cremonesi et al. (2006) for the S. aureus diagnosis, with good sensitivity and specificity, could be used in clinical samples too. The results showed that the following nucleotide sequences can be used as primers: F 5' AGC TGT GGA TTG TCC TTT GG 3' and R 5' TCG CTC GCT CAC CTT AGA A 3' in order to obtain a 499 pb enlargemenr are not useful in clinical samples due their low specificity (62.95%). It is required to search new primers to amplify S. aureus regions not shared with other bacteria, especially those cauding mastitis in dairy cows.

7.
Artif Organs ; 27(9): 792-801, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12940901

ABSTRACT

Severe sepsis and septic shock are the primary causes of multiple organ dysfunction syndrome (MODS), which is the most frequent cause of death in intensive care unit patients. Many water-soluble mediators with pro- and anti-inflammatory action such as TNF, IL-6, IL-8, and IL-10 play a strategic role in septic syndrome. In intensive care medicine, blocking any one mediator has not led to a measurable outcome improvement in patients with sepsis. CRRT is a continuously acting therapy, which removes in a nonselective way pro- and anti-inflammatory mediators; "the peak concentration hypothesis" is the concept of cutting peaks of soluble mediators through continuous hemofiltration. Furthermore, there is evidence of increased efficacy of high-volume hemofiltration compared to conventional CVVH, and other blood purification techniques that utilize large-pore membranes or sorbent plasmafiltration are conceptually interesting.


Subject(s)
Cytokines/physiology , Renal Replacement Therapy/methods , Sepsis/therapy , Acute Kidney Injury/etiology , Acute Kidney Injury/prevention & control , Critical Illness , Cytokines/metabolism , Humans , Multiple Organ Failure/etiology , Multiple Organ Failure/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...